| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/14/2015 | CN103127207B 一种采用酸催化增加黄芪总提取物中黄芪甲苷含量的方法 One kind of increase in the use of acid-catalyzed total Astragalus extract Astragaloside methods |
| 01/14/2015 | CN103119031B 取代酰胺化合物 Substituted amide compounds |
| 01/14/2015 | CN103071087B 戒酒药物 Drug and alcohol |
| 01/14/2015 | CN103005675B 一种铃兰花香型鼻烟及其制备方法 One kind of lily of the valley floral snuff and its preparation method |
| 01/14/2015 | CN102970982B 肠溶片剂 Enteric-coated tablets |
| 01/14/2015 | CN102961375B 一种ampk激活剂及其在制备治疗糖尿病和/或糖尿病并发症的药物中的应用 One kind ampk activator and its application in the preparation of the treatment of diabetes and / or complications of diabetes drugs in |
| 01/14/2015 | CN102958912B 二苯甲醇类衍生物、其制备方法及其在医药上的应用 Benzhydrol derivatives, their preparation and their use in medicine |
| 01/14/2015 | CN102850403B 一种水溶性铁羰基化合物及其制备方法和应用 A water-soluble iron carbonyl compound and its preparation method and application |
| 01/14/2015 | CN102406764B 抗骨髓炎片在制备治疗风热感冒药物中的应用 Anti osteomyelitis treatment tablets used in the preparation of a medicament Fengreganmao |
| 01/14/2015 | CN102311385B 具有糖皮质激素受体结合活性的1,2-二氢喹啉衍生物 Having a glucocorticoid receptor binding activity of 1,2-dihydro-quinoline derivative |
| 01/14/2015 | CN102283817B 可持续释放药物的组合物及其用途 Sustainable release pharmaceutical compositions and uses thereof |
| 01/14/2015 | CN102217878B 调档中药枕 Tiaodang the pillow |
| 01/14/2015 | CN101396411B 用于优生优育预防出生缺陷并且改善记忆的药物组合物 Pharmaceutical compositions for the prevention of birth defects and prenatal and postnatal care to improve memory |
| 01/13/2015 | USRE45337 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 01/13/2015 | USRE45336 Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 01/13/2015 | US8933224 Triazine derivatives |
| 01/13/2015 | US8933221 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
| 01/13/2015 | US8933090 1-aza-bicyclo[3.3.1]nonanes |
| 01/13/2015 | US8933029 Antimicrobial and anti-inflammatory peptides |
| 01/13/2015 | US8933027 Method of treating a disease or condition characterised by aberrant epithelial cell proliferation |
| 01/13/2015 | US8933022 Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
| 01/13/2015 | US8932630 Opioid agonist/antagonist combinations |
| 01/13/2015 | CA2804173C Sulfonamide nav1.7 inhibitors |
| 01/13/2015 | CA2681030C Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 01/13/2015 | CA2670858C Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 01/13/2015 | CA2580730C Tetrahydroindolone derivatives for treatment of neurological conditions |
| 01/08/2015 | WO2015002537A1 Amino acid composition for use in the treatment of a pdd |
| 01/08/2015 | WO2015002527A1 Amino acid composition for use in the treatment of a pdd |
| 01/08/2015 | WO2015002450A1 Pharmaceutical composition for preventing or treating cognitive impairment or concentration impairment disorders, comprising eclalbasaponin or derivative thereof |
| 01/08/2015 | WO2015002231A1 Heterocyclic compound |
| 01/08/2015 | WO2015002230A1 Amide compound |
| 01/08/2015 | WO2015002150A1 Novel compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor |
| 01/08/2015 | WO2015002119A1 Pyrazole-alcohol compound and pharmaceutical application therefor |
| 01/08/2015 | WO2015002118A1 Fluorene-amide compound and pharmaceutical application therefor |
| 01/08/2015 | WO2015001488A1 Extended-release tablets of paliperidone and processes of preparation thereof |
| 01/08/2015 | WO2015001379A1 Tauroursodeoxycholic acid (tudca) for use in the treatment of neurodegenerative disorders |
| 01/08/2015 | WO2015001352A1 Novel regenerative therapy |
| 01/08/2015 | WO2015001099A1 Varenicline and/or topiramate for use in the treatment of behavioral disorders and/or angina pectoris |
| 01/08/2015 | WO2015000921A1 Ptgds pathway activators and use in pathologies characterized by altered myelination in the cns |
| 01/08/2015 | WO2015000833A1 1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form |
| 01/08/2015 | WO2015000800A1 Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord motor disorders |
| 01/08/2015 | WO2015000412A1 Benzocyclobutene derivative and preparation method and pharmaceutical application thereof |
| 01/08/2015 | WO2015000370A1 Pyrroloquinoline quinone lithium salt crystal and preparation method and application thereof |
| 01/08/2015 | WO2015000035A1 Method for preventing and/or treating chronic traumatic encephalopathy-iv |
| 01/08/2015 | WO2015000034A1 Method for preventing and/or treating chronic traumatic encephalopathy-iii |
| 01/08/2015 | WO2015000033A1 Method for preventing and/or treating chronic traumatic encephalopathy-ii |
| 01/08/2015 | WO2015000032A1 Method for preventing and/or treating chronic traumatic encephalopathy-i |
| 01/08/2015 | WO2014153226A9 Arginine methyltransferase inhibitors and uses thereof |
| 01/08/2015 | US20150011577 Oxymorphone controlled release formulations |
| 01/08/2015 | US20150011563 Treating Sexual Desire Disorders with Flibanserin |
| 01/08/2015 | US20150011514 Celecoxib Compositions |
| 01/08/2015 | US20150011006 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/08/2015 | US20150010576 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/08/2015 | DE102013011397A1 Acethylcholin-Esterasehemmer als Mittel zur Reduktion von Folgen erhöhten Stresses bzw. ihrer Prävention - bei iatrogenen Cushing-Syndrom und anderer, ua durch die HPA-Achse vermittelten unerwünschten Wirkungen bei hochdosierter, lange dauernder Gluto Acetylcholine esterase as a means to reduce stress and its consequences increased prevention - in iatrogenic Cushing's syndrome and other, including mediated by the HPA axis adverse effects with high-dose, long lasting Gluto |
| 01/07/2015 | EP2821504A1 Method for designating disease relating to amount of tdp-43 existing in cells |
| 01/07/2015 | EP2821481A1 Culture medium for preparing neural stem cells and use thereof |
| 01/07/2015 | EP2821406A1 Novel piperidine compound or salt thereof |
| 01/07/2015 | EP2821401A1 Heterocyclic compound and use therefor |
| 01/07/2015 | EP2821073A1 Circadian rhythm-improving agent |
| 01/07/2015 | EP2821072A1 Pharmacological stimulation to facilitate and restore standing and walking functions in spinal cord disorders |
| 01/07/2015 | EP2821070A1 Adhesive skin patch |
| 01/07/2015 | EP2820042A2 Igg stimulated remyelination of peripheral nerves |
| 01/07/2015 | EP2820016A1 N- (5s, 6s, 9r) - 5 -amino- 6 - (2, 3 - difluorophenyl) -6, 7, 8, 9 - tetrahydro - 5h - cyclohepta [b]pyridin-9 -yl- 4 - (2 - oxo-2, 3 - dihydro - 1h- imidazo [4, 5 -b]pyridin - 1 - yl) piperidine - 1 - carboxylate, hemisulfate salt |
| 01/07/2015 | EP2820014A1 Heterobicyclic compounds and their use as phosphodiesterase inhibitors |
| 01/07/2015 | EP2820007A1 4,4-difluoro-piperidine-compounds |
| 01/07/2015 | EP2819749A2 Autism-associated biomarkers and uses thereof |
| 01/07/2015 | EP2819703A1 Pain treatment |
| 01/07/2015 | EP2819681A1 Method for improving functional synaptic connectivity |
| 01/07/2015 | EP2819674A2 Compositions and methods for the treatment of migraine |
| 01/07/2015 | EP2819664A1 New compositions for treating amyotrophic lateral sclerosis |
| 01/07/2015 | EP2819663A1 New therapeutic approaches for treating parkinson's disease |
| 01/07/2015 | EP2819655A1 Use of modafinil in the treatment of cocaine addicts |
| 01/07/2015 | EP2819653A2 Tamper resistant immediate release formulations |
| 01/07/2015 | EP2819650A1 Hormone containing emulsion comprising krill phospholipids |
| 01/07/2015 | EP2819649A1 Hormone containing emulsion |
| 01/07/2015 | CN104271741A 用于治疗神经肌肉障碍的具有改善特性的rna调节寡核苷酸 Rna for the treatment of neuromuscular disorders with improved characteristics adjustment oligonucleotide |
| 01/07/2015 | CN104271587A Hsp90C端抑制剂 Hsp90C end inhibitors |
| 01/07/2015 | CN104271581A 用作电压门控钠通道调制剂的2-(吡啶-2基)-1,7-二氮杂螺[4.4]壬-6-酮化合物 As a voltage-gated sodium channel modulators of 2- (pyridin-2-yl) -1,7-spiro [4.4] non-6-one compound |
| 01/07/2015 | CN104271578A 作为lrrk2调节剂用于治疗帕金森病的吡唑氨基嘧啶衍生物 As lrrk2 modulators for the treatment of Parkinson's disease pyrazole amino pyrimidine derivatives |
| 01/07/2015 | CN104271574A 杂环化合物 Heterocyclic Compounds |
| 01/07/2015 | CN104271569A 作为lrrk2调节剂的吡唑氨基嘧啶衍生物 As pyrazole-aminopyrimidine derivative lrrk2 moderator |
| 01/07/2015 | CN104271566A 取代的联吡啶胺及其用途 Substituted bipyridyl amine and their use |
| 01/07/2015 | CN104271558A β-分泌酶抑制剂 β- secretase inhibitors |
| 01/07/2015 | CN104271553A 杂环化合物和它们的使用方法 Heterocyclic compounds and methods for their use |
| 01/07/2015 | CN104271137A 包含封装在水不溶性袋中的粉末的尼古丁口服递送产品,其中所述粉末包括尼古丁和口香糖组合物 Comprising nicotine encapsulated in a water-insoluble oral powder delivery bag product, wherein the powder comprises a nicotine chewing gum compositions |
| 01/07/2015 | CN104271131A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并[3,4,b]吲哚]-4-胺和抗抑郁药的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol pyrano [3,4, b] indole] -4-amine and pharmaceutical compositions of antidepressants |
| 01/07/2015 | CN104263608A 一种保健酒的制备方法 Preparation of a health wine |
| 01/07/2015 | CN104263596A 一种助眠安神保健饮料及其制备方法 One kind of sleep aids sedative health drink and its preparation method |
| 01/07/2015 | CN104263592A 一种生津荸荠金针菇饮料 One kind of fluid and water chestnuts, mushroom beverage |
| 01/07/2015 | CN104263578A 一种银杏枸杞风味米酒的制作工艺 The production process of a ginkgo wolfberry wine flavor |
| 01/07/2015 | CN104263572A 一种安眠葡萄酒及其制备方法 A wine and its preparation method sleep |
| 01/07/2015 | CN104262463A 蚕蛹多肽及其制备方法、应用 Pupa polypeptides and preparation methods, application |
| 01/07/2015 | CN104262462A 葡萄糖转运蛋白抑制多肽及其制备方法、应用 Inhibition of glucose transport protein polypeptides and preparation methods, application |
| 01/07/2015 | CN104262461A α-芋螺毒素肽TxIC、其药物组合物、其制备方法及用途 α- conotoxin peptide TxIC, pharmaceutical compositions thereof, their preparation and use |
| 01/07/2015 | CN104262348A 一种α7烟碱型乙酰胆碱受体配体及其制备方法 One kind of α7 nicotinic acetylcholine receptor ligand and its preparation method |
| 01/07/2015 | CN104262330A 新型脲取代联苯类化合物及其组合物及用途 Novel substituted diphenyl urea compounds and compositions and uses |
| 01/07/2015 | CN104262328A 抑制btk和/或jak3激酶活性的化合物 Inhibition btk and / or kinase activity of a compound jak3 |
| 01/07/2015 | CN104262302A L-抗坏血酸-6-(e-2-癸烯酸)酯或其衍生物以及它们的应用 L- ascorbic acid -6- (e-2- decanoic acid) ester or a derivative thereof and their applications |
| 01/07/2015 | CN104262292A 苯乙酸酯化合物及其应用 Phenylacetic acid ester compounds and uses thereof |
| 01/07/2015 | CN104262267A 用于治疗前列环素(pgi2)受体相关病症的pgi2受体调节剂 Pgi2 receptor modulator for the treatment of prostacyclin (pgi2) receptor related disorders |